HealthDay - WEDNESDAY, Nov. 9 (HealthDay News) -- For the first time, "epigenetic" therapy has shown promise in patients with solid tumors, in this case non-small cell lung cancers.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.